A Small Molecule Disruptor of Rb/Raf-1 Interaction Inhibits Cell Proliferation, Angiogenesis, and Growth of Human Tumor Xenografts in Nude Mice
Open Access
- 15 May 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (10), 3810-3818
- https://doi.org/10.1158/0008-5472.can-07-6672
Abstract
Although it is well established that cyclin-dependent kinases phosphorylate and inactivate Rb, the Raf-1 kinase physically interacts with Rb and initiates the phosphorylation cascade early in the cell cycle. We have identified an orally active small molecule, Rb/Raf-1 disruptor 251 (RRD-251), that potently and selectively disrupts the Rb/Raf-1 but not Rb/E2F, Rb/prohibitin, Rb/cyclin E, and Rb/HDAC binding. The selective inhibition of Rb/Raf-1 binding suppressed the ability of Rb to recruit Raf-1 to proliferative promoters and inhibited E2F1-dependent transcriptional activity. RRD-251 inhibited anchorage-dependent and anchorage-independent growth of human cancer cells and knockdown of Rb with short hairpin RNA or forced expression of E2F1 rescued cells from RRD-251–mediated growth arrest. P.o. treatment of mice resulted in significant tumor growth suppression only in tumors with functional Rb, and this was accompanied by inhibition of angiogenesis, inhibition of proliferation, decreased phosphorylated Rb levels, and inhibition of Rb/Raf-1 but not Rb/E2F1 binding in vivo. Thus, selective targeting of Rb/Raf-1 interaction seems to be a promising approach for developing novel chemotherapeutic agents. [Cancer Res 2008;68(10):3810–8]Keywords
Other Versions
This publication has 52 references indexed in Scilit:
- In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trialsMolecular Cancer Therapeutics, 2006
- Distinct Action of the Retinoblastoma Pathway on the DNA Replication Machinery Defines Specific Roles for Cyclin-Dependent Kinase Complexes in Prereplication Complex Assembly and S-Phase ProgressionMolecular and Cellular Biology, 2006
- Nicotine induces cell proliferation by -arrestin-mediated activation of Src and Rb-Raf-1 pathwaysJCI Insight, 2006
- Prohibitin Facilitates Cellular Senescence by Recruiting Specific Corepressors To Inhibit E2F Target GenesMolecular and Cellular Biology, 2006
- p18Ink4c and Pten Constrain a Positive Regulatory Loop between Cell Growth and Cell Cycle ControlMolecular and Cellular Biology, 2006
- PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancerCancer Detection Prevention, 2005
- A New ex vivo Model to Study Venous Angiogenesis and Arterio-Venous Anastomosis FormationJournal of Vascular Research, 2005
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Mutations of the BRAF gene in human cancerNature, 2002